JDRF T1D Fund

16 Jun 2020

$4,500,000

Seed fund

Boehringer Ingelheim Venture Fund, JDRF T1D Fund, Advent France Biotechnology (AFB)

DiogenX Raises €4.5M in Seed Financing

Sanofi-Genzyme BioVentures, JDRF T1D Fund

18 May 2020

$65,000,000

Venture capital (Series D)

Polaris Partners, Invus, Temasek Holdings, +4

This MIT PhD Just Raised $65 Million For His Clinical Stage Cell Therapy Company

Forbes

09 Apr 2020

$4,000,000

Seed fund

i2O Therapeutics Raises $4m in Seed Funding

06 Mar 2020

$130,000,000

Venture capital (Series B)

General Atlantic, Rock Springs Capital, CCB International, +3

Clinical-Stage T Cell Receptor Biotech Company Immunocore Raises Over $130 Million

Pulse 2.0

10 Oct 2019

$10,000,000

Venture capital (Series A)

Morningside Ventures, JDRF T1D Fund, Colorado University Healthcare Innovation Fund

IM Therapeutics locks in $10 mln Series A

19 Dec 2018

Undisclosed funding

Pandion Therapeutics lands funding

11 Sep 2018

Undisclosed funding

ImmusanT rakes in funding

18 Dec 2017

$37,000,000

Venture capital (Series B)

Visionnaire Ventures, Quadrant Capital Advisors, Janus Capital Group, +3

29 Nov 2017

$114,000,000

Venture capital (Series B)

ARCH Venture Partners, MPM Capital, Novartis, +5

05 Jul 2017

$30,000,000

Venture capital

JDRF T1D Fund, Black Beret Life Sciences, McDonald Partners, +1

Diasome lands $30m to fund clinical trials of liver-targeted insulin

Drug Delivery Business

02 May 2017

Undisclosed funding

Biopharma company TetraGenetics grabs funding

23 Mar 2017

Venture capital

MPM Capital, Novartis, Medtronic, +2

Semma Therapeutics Raises Additional Funding

16 Feb 2017

$2,000,000

Grant